PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 91 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,148,000 | +151.5% | 56,912 | +117.7% | 0.00% | 0.0% |
| Q1 2018 | $854,000 | -66.5% | 26,147 | -50.0% | 0.00% | -33.3% |
| Q4 2017 | $2,546,000 | +754.4% | 52,294 | +850.8% | 0.00% | +200.0% |
| Q3 2017 | $298,000 | -11.6% | 5,500 | -36.1% | 0.00% | 0.0% |
| Q1 2017 | $337,000 | +42.8% | 8,607 | -18.3% | 0.00% | 0.0% |
| Q4 2016 | $236,000 | +1.7% | 10,531 | +3.0% | 0.00% | 0.0% |
| Q3 2016 | $232,000 | -94.6% | 10,221 | -94.4% | 0.00% | -90.9% |
| Q2 2016 | $4,328,000 | +15.6% | 183,370 | -0.0% | 0.01% | +22.2% |
| Q1 2016 | $3,743,000 | -60.3% | 183,453 | +0.1% | 0.01% | -57.1% |
| Q4 2015 | $9,432,000 | -1.3% | 183,324 | -18.3% | 0.02% | 0.0% |
| Q3 2015 | $9,559,000 | +4.8% | 224,289 | +12.0% | 0.02% | +16.7% |
| Q2 2015 | $9,119,000 | +20.4% | 200,200 | +0.3% | 0.02% | +20.0% |
| Q1 2015 | $7,577,000 | +34.0% | 199,600 | 0.0% | 0.02% | +25.0% |
| Q4 2014 | $5,653,000 | +12.0% | 199,600 | 0.0% | 0.01% | +9.1% |
| Q3 2014 | $5,046,000 | -13.4% | 199,600 | 0.0% | 0.01% | -15.4% |
| Q2 2014 | $5,824,000 | +12.2% | 199,600 | -0.4% | 0.01% | +8.3% |
| Q1 2014 | $5,190,000 | +0.8% | 200,400 | +0.2% | 0.01% | 0.0% |
| Q4 2013 | $5,150,000 | -3.7% | 200,000 | 0.0% | 0.01% | -14.3% |
| Q3 2013 | $5,350,000 | +8.9% | 200,000 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $4,914,000 | – | 200,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |